ADC Cytotoxin are a large collection of toxins for antibody-drug conjugate (ADC) development projects. The toxins that can be used as payloads should be soluble, amenable to conjugation, and stable. There are myriads of cellular toxins in natural or synthesized, but only a few have been found adaptable for an ADC concept.
The toxins targeting tubulin filaments include Maytansinoids, Auristatins, Taxol derivatives, etc. Amatoxins are a class of transcription-inhibiting agents. They bind to RNA polymerase II, leading to cell apoptosis. Protein toxins function in the similar MOA (mechanism of action) with cellular toxins, they could inhibit protein synthesis and induce cell death. While enzyme-based ADCs alter the microenvironment of disease tissues to disturb their functions.
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
H9339 |
Nendratareotide Uzatansine |
1853254-97-3 | Nendratareotide Uzatansine is a Somatostatin receptor 2 (SSTR2)-targeting cytotoxic conjugate with an IC50 of 10 nM. |
H9335 |
Locnartecan |
1472614-83-7 | Locnartecan is a potential agent for controlling early stage tumor growth for non-small cell lung cancer (NSCLC). PEN-866 is a novel esterase-cleavable conjugate of an HSP90i and a topoisomerase I inhibitor, SN-38. |
H9316 |
ANG-1005 |
1075214-55-9 | ANG1005 is a novel taxane derivative, consists of three paclitaxel molecules covalently linked to Angiopep-2, designed to cross the blood–brain and blood–cerebrospinal barriers and to penetrate malignant cells via LRP1 transport system. |
H8800 |
Clezutoclax |
1949843-71-3 | Clezutoclax is a novel preparation of Bcl-xL inhibitory compounds having low cell permeability and antibody drug conjugates. |
H8799 |
Deruxtecan |
1599440-13-7 | Deruxtecan is an ADC drug-linker conjugate composed of a derivative of DX-8951 (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402. |
H8565 |
McMMAF |
863971-19-1 | Mafodotin is a MMAF derivative having a Maleimidocaproyl linker (MC linker), which is ready to conjugate to antibody or other proteins or biopolymers. Mafodotin is a useful agent for make antibody drug conjugate (ADC) for targeted drug delivery. MMAF is a potent antimitotic and antitublin auristatin derivative with a charged C-terminal phenylalanine residue that attenuates its cytotoxic activity compared to its uncharged counterpart, MMAE. |
H8404 |
MMAF-OMe |
863971-12-4 | An antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin. It is linked to an antibody with high affinity to structures on cancer cells, causing MMAF to accumulate in such cells; an ADC payload. |
H8403 |
MMAD hydrochloride |
173441-26-4 | A potent tubulin inhibitor that is a toxin payload in antibody drug conjugates (ADCs). |
H8402 |
Ansamitocin P-3 |
66547-09-9 | A microtubule depolymerizing agent that can be isolated from culture broths of certain Gram-positive bacteria; binds tubulin (Kd=1.3 uM), depolymerizes microtubules in both interphase and mitosis, and perturbs chromosome segregation; inhibits the growth of cancer cells in culture and significantly suppresses the growth of several cancer tumors in mice. |
H8401 |
Maytansinol |
57103-68-1 | Maytansinol (Ansamitocin P-0) is a microtubule assembly inhibitor; ADC payload in development of antibody drug conjugates. |
086-18516630705
sales@hmobio.com
1/F, building 4, No. 358-368, Kefu Road, Jiading District, Shanghai, China